Skip to content
← Back to this collection

PUBLICATIONS · 30275289

FDA Approves AZEDRA Specified Use in Pheochromocytomas/Paragangliomas.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Nucl Med
Publication date
2018 Oct
First author
Source null

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

      Complete bibliographic record and source provenance
      authors
        bibliography ids
        1. nci-bib-942e5e2791aa9365669b01dd
        book metadata
        content sha256
        d74b754d3e0610a06cb1a196f022cc57a9b920c26501ee2ad4ebec3724536740
        document type
        citation
        dois
          electronic publication date
          display
          Source null
          precision
          missing
          year
          Source null
          evidence scope
          bibliographic_metadata_only
          id
          pubmed:30275289
          immutable id
          pubmed:30275289@d74b754d3e0610a06cb1a196f022cc57a9b920c26501ee2ad4ebec3724536740
          journal
          abbreviation
          J Nucl Med
          issn electronic
          1535-5667
          issn print
          0161-5505
          issue
          10
          name
          Journal of nuclear medicine : official publication, Society of Nuclear Medicine
          nlm unique id
          0217410
          pages
          17N
          volume
          59
          languages
          1. eng
          notices
          absence is not clearance
          true
          has correction metadata
          false
          has expression of concern metadata
          false
          has retraction in link
          false
          pubmed marks article retracted
          false
          pubmed marks retraction notice
          false
          relationships
            outcomes validated
            false
            pmid
            30275289
            provenance
            batch id
            438b2803888025c6cf56
            provider
            NCBI PubMed ESummary
            record sha256
            2adb0197b11b0da4acd1026cbc416789bfad4267f064959f3246ab6ce671c455
            response sha256
            0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
            retrieved at
            2026-09-09T23:47:36.359220+00:00
            publication date
            display
            2018 Oct
            precision
            month
            year
            2018
            publication types
            1. Journal Article
            record status
            PubMed
            schema version
            1.0
            source url
            https://pubmed.ncbi.nlm.nih.gov/30275289/
            title
            FDA Approves AZEDRA Specified Use in Pheochromocytomas/Paragangliomas.

            Preserved source evidence · Not medical advice